Publisher
Springer International Publishing
Reference83 articles.
1. Akkus E, Carrier S, Rehman J, Breza J, Kadioglu A, Lue TF (1994) Is colchicine effective in Peyronie’s disease? A pilot study. Urology 44:291–295
2. Akman T, Sanli O, Uluocak N, Akbulut F, Nane I, Demir S, Kadioglu A (2011) The most commonly altered type of Peyronie’s disease deformity under oral colchicine treatment is lateral curvature that mostly shifts to the dorsal side. Andrologia 43:28–33
3. Anderson MS, Shankey TV, Lubrano T, Mulhall JP (2000) Inhibition of Peyronie’s plaque fibroblast proliferation by biologic agents. Int J Impot Res 12:25–31
4. Astsaturov I, Petrella T, Bagriacik EU, de Benedette M, Uger R, Lumber G, Berinstein N, Elias I, Iscoe N, Hammond C, Hamilton P, Spaner DE (2003) Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha2b: implications for cancer vaccines. Clin Cancer Res 9:4347–4355
5. Avilés A, Neri N, Huerta-Guzmán J, Pérez F, Sotelo L (2004) Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma. Leuk Lymphoma 45:2247–2251